United Kingdom was report the mutation of the SARS-CoV-2 virus on December 14, 2020. Mutations of variant B117 have been reported in 33 countries.
Researchers indicated that variant B.1.1.7 is transmissible more rapidly and is more infectious. However, to date there is no evidence that variant B.1.1.7 causes more severe disease symptoms or a higher mortality rate.
Various countries have vaccinated against COVID-19 in several populations. Can the COVID-19 vaccination also protect the population from the SARS-CoV-2 B117 virus variant?
Research on this virus and its vaccine is still developing, researchers state that the COVID-19 vaccine that has received a distribution license also provides protection for the B117 variant. The vaccines that have been circulated trigger a fairly broad immune response, so that mutations in the virus will not affect the effectiveness of the vaccine.
What should be done to prevent infection with the new variant B.1.1.7?
Everyone should focus on preventing transmission to prevent infections that can complicate the health system.
- Perform testing, tracking and tracing.
- Isolate everyone who comes in contact with the infected patient.
- Vaccination to form antibodies against SARS-C0V-2 and the new variant B117.
ayo segera bergabung dengan saya di D3W4PK
ReplyDeletehanya dengan minimal deposit 10.000 kalian bisa menangkan uang jutaan rupiah
ditunggu apa lagi ayo segera bergabung, dan di coba keberuntungannya
untuk info lebih jelas silahkan di add Whatshapp : +8558778142
terimakasih ya waktunya ^.^